文献速递主动脉疾病

钝性胸主动脉损伤TEVAR中左锁骨下动脉处理策略比较

Left subclavian artery management strategies during thoracic endovascular aortic repair for blunt thoracic aortic injury: Do branched endografts offer a clinical advantage?
PubMed 文献 · J Vasc Surg · 2026-09-10

基于VQI注册数据库比较钝性胸主动脉损伤行zone 2 TEVAR时左锁骨下动脉覆盖不重建、分支支架或颈锁旁路三种策略,纳入416例患者,30天死亡率、卒中及上肢缺血无显著差异,CSB+TEVAR再干预率更高,提示可快速TEVAR并选择性延迟重建。

要点

  • BTAI行zone 2 TEVAR时LSA覆盖不重建、TBE与CSB+TEVAR主要并发症无显著差异。
  • CSB+TEVAR的主动脉或上肢缺血相关再干预率更高(13.3% vs 2.7% vs 1.5%,P=.044)。
  • 提示可优先快速TEVAR、选择性延迟LSA重建,而非常规预防性干预。

核心结论

  • BTAI患者行zone 2 TEVAR时,不同LSA处理策略在主要神经或缺血并发症上未检测到统计学显著差异。
  • 结果支持务实的损伤控制策略,即快速TEVAR并选择性延迟血运重建,而非常规预防性LSA干预。

研究设计与样本

  • 基于血管外科学会VQI TEVAR注册数据库的回顾性队列分析,纳入2013年至2026年4月因BTAI行zone 2 TEVAR的患者。
  • 共纳入416例,分为LSA覆盖不重建组327例、分支支架组74例、颈锁旁路加TEVAR组15例。

主要发现

  • 30天死亡率分别为LSA覆盖11.6%、TBE 5.4%、CSB+TEVAR 0%,P=.113。
  • 卒中发生率分别为5.2%、5.4%、6.7%,上肢缺血分别为2.4%、1.4%、6.7%,组间无显著差异。
  • 脊髓缺血罕见,分别为1.8%、0%、6.7%。
  • 主动脉或上肢缺血相关再干预率分别为2.7%、1.5%、13.3%,CSB+TEVAR更高,P=.044。
  • 总体再干预率和生存率组间无显著差异。

临床怎么用

  • 对于BTAI需zone 2 TEVAR的患者,可优先快速完成TEVAR,LSA覆盖后按需选择性延迟血运重建。
  • 颈锁旁路加TEVAR与更高的再干预率相关,应权衡常规预防性LSA重建的必要性。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare outcomes of left subclavian artery (LSA) management strategies during thoracic endovascular aortic repair (TEVAR) for blunt thoracic aortic injury (BTAI) using a national registry. METHODS: The Society for Vascular Surgery Vascular Quality Initiative TEVAR registry was queried for patients undergoing zone 2 TEVAR for BTAI from 2013 through April 2026. Patients were stratified into LSA coverage without revascularization, TEVAR with branched endograft (TBE), or carotid-subclavian bypass with TEVAR (CSB+TEVAR). Primary outcomes were 30-day mortality and arm ischemia. Secondary outcomes included stroke, spinal cord ischemia, and reintervention. Kaplan-Meier survival analysis and adjusted TBE vs coverage sensitivity analyses were performed. RESULTS: A total of 416 patients were included (LSA coverage, n = 327; TBE, n = 74; CSB+TEVAR, n = 15). Patients undergoing LSA coverage were younger and more frequently presented with rupture. Thirty-day mortality was 11.6%, 5.4%, and 0%, respectively (P = .113). Stroke (5.2% vs 5.4% vs 6.7%) and arm ischemia (2.4% vs 1.4% vs 6.7%) were not significantly different across groups. Spinal cord ischemia was rare (1.8%, 0%, and 6.7%). Aortic- or arm ischemia-related reintervention was more frequent after CSB+TEVAR (13.3% vs 2.7% vs 1.5%; P = .044). Overall reintervention and survival did not differ significantly among groups. CONCLUSIONS: In patients undergoing zone 2 TEVAR for BTAI, no statistically significant differences were detected in major neurologic or ischemic complications among LSA management strategies. These findings suggest a pragmatic, damage-control approach favoring rapid TEVAR with selective delayed revascularization rather than routine prophylactic LSA intervention.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Baghbani A, Dominguez G, Jackson ML, et al. Left subclavian artery management strategies during thoracic endovascular aortic repair for blunt thoracic aortic injury: Do branched endografts offer a clinical advantage? J Vasc Surg. 2026. PMID: 42716262. doi:10.1016/j.jvs.2026.07.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。